Log in to save to my catalogue

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4859b9f084574d6c80a43d2b5b37a642

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage

About this item

Full title

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage

Publisher

Los Angeles, CA: SAGE Publications

Journal title

Cancer control, 2021, Vol.28, p.10732748211048292-10732748211048292

Language

English

Formats

Publication information

Publisher

Los Angeles, CA: SAGE Publications

More information

Scope and Contents

Contents

Purpose
Serum carcinoembryonic antigen (SCEA) level is often measured in patients with CRC but suffers from poor sensitivity and specificity as a diagnostic biomarker. CEA is more abundant in stool than in serum, but it has not been widely studied. This study aimed to elucidate the efficacy of fecal CEA (FCEA) as a potential non-invasive biomark...

Alternative Titles

Full title

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4859b9f084574d6c80a43d2b5b37a642

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4859b9f084574d6c80a43d2b5b37a642

Other Identifiers

ISSN

1073-2748

E-ISSN

1526-2359,1073-2748

DOI

10.1177/10732748211048292

How to access this item